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Objectives: To evaluate midterm patency of saphenous vein grafts harvested endoscopically
and identify risk factors for subsequent vein graft occlusion.
Methods: Fifty consecutive patients undergoing coronary artery bypass surgery with venous
graft harvested by endoscopic method were included in the study. Patients underwent
computed tomography angiography follow-up at mean 24 months. Multivariate  logistic re-
gression was used to analyze associations between preoperative variables (age, ejection
fraction, body mass index, gender, hyperlipidemia, hypertension, diabetes mellitus, smoking,
number of defects per graft and target vessel stenosis) and the incidence of saphenous vein
graft occlusion.
Results: Occlusion of the saphenous vein graft occurred in 7 patients (14.3%) and occlusion of
the left internal mammary artery graft in 1 patient (2.3%) during the 24 months after surgery.
No signiﬁcant stenosis (i.e. narrowing by >50%) was found in the remaining grafts. Multi-
variate logistic regression found no association between preoperative variables and saphe-
nous vein graft occlusion.
Conclusions: Patency rates 2 years after endoscopic vein harvesting are comparable to those
from open techniques. Our data indicated no association between preoperative variables
and vein graft occlusion. These results support the use of endoscopic saphenectomy in a
wide spectrum of patients undergoing coronary artery bypass surgery.
# 2014 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp. z o.o.
All rights reserved.
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http://www.elsevier.com/locate/crvasa
.Introduction
The traditionally harvested saphenous vein still remains the
most frequently used graft for coronary artery bypass grafting* Corresponding author at: Cardiac Surgery Department, Hospital of Če
Czech Republic. Tel.: +420 387874201; fax: +420 387874202.
E-mail addresses: vojtech.kurﬁrst@post.cz (V. Kurﬁrst), canadyo
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0010-8650/# 2014 The Czech Society of Cardiology. Published by Else(CABG) [1]. Complications associated with the method, such as
hematoma, dehiscence, skin necrosis or infection, increase the
length of stay and hospital costs [2]. Aiming to decrease wound
complications and obtain better cosmetic results, endoscopic
vein harvest has become an alternative for patients undergoingské Budějovice, Boženy Němcové str. 54, České Budějovice 37087,
va.julia@gmail.com (J. Čanádyová), jkubale@atlas.cz (J. Kubále),
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Table 1 – Patient characteristics.
Preoperative variables n %
No. 49
Male 37 75.5
Mean age (years) 66.4  6.1
Mean BMI 29.4  3.2
Mean ejection fraction 58.6  10.4
Smoking 10 20.4
Hypertension 41 83.7
History of MI 24 48.9
History of TIA/stroke 2 4.1
Diabetes mellitus 18 36.7
Hyperlipidemia 35 71.4
Varicose veins 11 22.4
Ischemic disease of
lower extremities
2 4.1
COPD 9 18.4
BMI, body mass index; COPD, chronic obstructive pulmonary
disease; MI, myocardial infarction; TIA, transitory ischemic attack.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 2 4 0 – e 2 4 5 e241surgical revascularization [1,3–9]. After initial distrust in the
quality of grafts harvested endoscopically, several works were
published that conﬁrmed the same graft patency compared
with grafts from traditional harvest, although most of these
works evaluated short-term results [10]. The primary objective
of this study was to evaluate midterm patency of saphenous
vein grafts harvested using the endoscopic method. A second-
ary objective was to identify possible risk factors for vein graft
occlusion.
Materials and methods
Study population
From September 2010 to December 2010, 50 patients undergo-
ing primary cardiac surgery (74% of primary CABG and 26% of
CABG + valve replacement/repair) at the Cardiac Surgery
Department of the Hospital of České Budějovice were included
in the study. All procedures were performed in a standard
manner on extracorporeal circulation and during heart arrest.
There were no off-pump procedures in the study population.
The grafts used during these revascularization procedures
were the left internal mammary artery (LIMA) for the left
anterior descending artery (LAD) and vein grafts for remaining
coronary arteries. The study was approved by the local ethics
committee. The inclusion criteria were the following: elective
cardiac surgery, agreement to participate in the study and
written informed consent. Patients undergoing urgent cardiac
surgery as well as patients who refused to participate in the
study were excluded.
Surgical technique
Endoscopic harvests were carried out by two residents using
ClearGlide instrumentation (Sorin Group). The harvest was
initiated with a longitudinal incision 3 cm long above the right
or left knee. V. saphena magna was prepared and hung on a
rubber tourniquet. The dissection then continued and was
performed ﬁrst with an optical dissector (tunneling) and then
with an optical retractor and bipolar electrocoagulator to
interrupt the outgoing branches. The harvest utilized a no-
touch technique and included the vein's surrounding tissue.
The ClearGlide instrumentation is an open system which
enables harvesting the vein without insufﬂation of CO2 into
the subcutaneous tunnel. After completing the preparation
and release of the vein, the distal portion of the vein was
cannulated and cut off. The proximal vein was ligated in the
groin with an endoscopic loop and cut off using endoscopic
scissors. In this type of ligation it is possible to harvest a
venous graft with one cut. Finally, a drain was placed into the
subcutaneous tunnel and the skin was closed in one layer.
Vein grafts were routinely stored until use in saline.
CT angiography follow-up
The examination was carried out by multi-detector computed
tomography (CT) angiography using a 64-slice Toshiba
Aquilion CT apparatus. We followed the usual investigative
protocol for the examination of heart enlargement, setting thescanning ﬁeld to enable viewing all aortocoronary bypasses,
including the length of the LIMA. CT angiography was
performed with the administration of iodinated contrast
media and while synchronizing the scan with recording
ECG. A total of 100–120 ml of Iomeron 400 (Bracco Imaging,
Germany) contrast was administered according to the
patient's habitus (more contrast was administered to patients
with a larger chest dimension) at 5 ml/s using bolus tracking.
The start of scanning was for increased density in the
descending aorta to 100 HU. The scanning range was from
the sternoclavicular articulation to the base of the heart with
gentle breathing. Subsequently, reconstruction was performed
in different stages of the cardiac cycle using retrospective ECG
gating. Primarily automatic reconstruction was used via the
auto-phase program in systole and diastole. Reconstructions
were performed in other targeted phases if the image in one of
these phases was physically fuzzy. Patients were requested to
fast for at least 3 hours before the testing. Most patients were
being medicated with beta blocker for chronic conditions. The
total examination time was about 20 min, out of which the
Custom Scan required 10–20 s. Most of the time was spent
preparing the patient and the examination protocol. Subse-
quent reconstruction can take up to 2 h. The total effective
radiation dose for the examination was about 34 mSv.
Statistics
Continuous variables with normal distributions are expressed
as means  1 standard deviation. Those with a non-normal
distribution (age, left ventricular function, body mass index
and vein length), as assessed by the Shapiro–Wilk test for
normality, were tested using the nonparametric Mann–
Whitney U test for 10 categorical variables (patient's char-
acteristics, graft characteristics and target vessel properties),
which were tested for their inﬂuence on vein graft patency by
using a chi-square test or Fisher's exact test, as appropriate.
Statistical analysis was performed using GraphPad Prism5
software. Multivariate logistic regression was used to analyze
the association between preoperative variables (age, ejection
Table 2 – Target vessel characteristics.
Target vessels' characteristics. n = 77 %
Total number of vein graft anastomosis 77 100
RD target vessel 17 22.1
LCx target vessels 38 49.3
RCA target vessels 22 28.6
Stenosis of target vessel ≤70% 26 33.8
Stenosis of target vessel >70% 39 50.6
Occlusion of target vessel 12 15.6
History of PCI on target vessel 3 3.9
PCI, percutaneous coronary intervention; RCA, right coronary
artery; LCx, left circumﬂex artery; RD, ramus diagonalis.
Table 4 – Multivariate analysis of the quantitative
parameters and results of nonparametric Mann–Whitney
tests comparing patients with occluded bypasses and
patients with patent bypasses.
Risk
factor
Graft
occlusion
No. Mean SD Mann–Whitney
test
P
Age Yes 7 63.14 7.967 129.5 0.6266
No 42 64.69 8.794
EF Yes 7 61.57 13.58 118.5 0.4229
No 42 57.62 13.45
BMI Yes 7 27.23 4.217 104.5 0.2299
No 42 29.60 4.050
BMI, body mass index; EF, ejection fraction.
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hypertension, diabetes mellitus, smoking, number of defects
per graft and target vessel stenosis) and the incidence of
saphenous vein graft occlusion.
Results
Of the total 50 patients, 1 patient died 11 months after the
surgery from a cerebrovascular accident and was removed
from the study. The preoperative proﬁles of the remaining 49
patients are presented in Table 1. The mean length of vein
graft was 24.1 cm (SD 3.8), and 32.7% of vein grafts needed
suture of a defect in the vein. The most bypassed target vessel
was left circumﬂex artery (49.3%). There were 40 LIMA to LAD
bypasses, 40 single venous bypasses, 12 single sequential
bypasses (2 distal anastomoses), 3 double sequential bypasses
(3 distal anastomoses) and 1 triple sequential bypass (4 distal
anastomoses) which made together 77 distal venous anasto-
moses (Table 2). Other perioperative variables are listed in
Table 3. In the post-operative period, wound healing compli-
cations occurred in 3 patients. One patient experienced wound
infection requiring a prolonged hospital stay and the use of
intravenous antibiotics. Two patients experienced lymphatic
secretion and were treated conservatively by systematic
bandaging of the leg, which resolved the condition in two
weeks (Table 3). No patient experienced acute symptomatic
graft closure. The overall two-year vein occlusion rate was
14.3% (7 vein grafts). CT angiography found no severe stenosis
(i.e. narrowing by >50%) in the remaining grafts. In the
statistical analysis, 10 categorical variables (patient's char-
acteristics, graft characteristics and target vessel properties)
were tested for their inﬂuence on midterm vein graft patency.
There are general fears that a higher number of suture repairs
of torn side branches will have a negative inﬂuence on graft
patency. In this study, of 33 vein grafts without suture repair
there were 5 grafts (15.2%) occluded in comparison toTable 3 – Post-operative harvest site complications.
Post-operative complication n %
Revision for bleeding after endoscopic harvest 0 0
Hematoma 0 0
Infection 1 2.0
Lymphatic secretion 2 4.1occlusion of 2 grafts out of 12 vein grafts with 1 suture repair
of torn side branches (16.7%) and no occlusion of 4 grafts with 2
suture repairs. These differences were not statistically
signiﬁcant (x2 = 0.7424, P = 0.6899). No association between
severity of target vessel stenosis and graft occlusion could be
determined. In the group of patients with target vessel
stenosis less than 70%, vein graft patency was 85% (22/26)
(not signiﬁcant, P = 1.0, relative risk = 1.014, 95% CI: 0.8020–
1.283). In patients with target vessel stenosis of 70% or greater,
patency was 82.1% (32/39) (not signiﬁcant, P = 0.4363, relative
risk = 1.116, 95% CI: 0.8925–1.395). From the remaining vari-
ables (age, ejection fraction, BMI, sex, hypertension, hyperlip-
idemia, diabetes mellitus, and smoking), the multivariate
analysis found no relationship between them and occlusion of
the saphenous vein graft (Table 4 and Table 5).
Discussion
The great saphenous vein is the traditionally and most
commonly used conduit in coronary artery bypass surgery
[1]. The open surgical technique is the standard method of
harvesting great saphenous vein with average length of
longitudinal incision varying from 20 cm to 40 cm, depending
on the required length of vein graft. Accord et al. evaluated
1577 patients in Maastricht who had undergone open harvest
of great saphenous vein and revealed that in 1.5% of patients
donor-site infections were diagnosed before discharge. These
ﬁndings increased to 4.6% at 30-day follow-up and 7.3% at 90-
day follow-up [11]. Complications associated with the vein
graft harvesting procedure, such as infection, delayed healing
of the saphenous vein harvest site, patient discomfort from leg
incision and, last but not least, poor cosmetic result (which
remains an important issue for many patients), are well
documented [12–14]. Depending on wound deﬁnition, saphen-
ectomy wound complications have reported incidence of 1–
44% [15]. In a prospective randomized trial, endoscopically
harvested saphenous vein was associated with signiﬁcantly
fewer wound complications than where longitudinal method
was used (4% vs. 19%) [13].
With the growing interest in minimally invasive methods
for cardiac surgery, new and less-invasive methods of vein
harvesting have been developed. In recent years, the tunneling
technique (bridging technique) and endoscopic vein graft
Table 5 – Multivariate analysis of relationships between risk factors and occlusion of saphenous vein grafts.
Risk factors Graft occlusion Relative risk
(95% CI)
Odds ratio
(95% CI)
P
No Yes
Sex (female) 8 3 0.8128
(0.5570–1.186)
0.3137
(0.05824–1.690)
0.1782
Hypertension 34 7 1.206
(1.049–1.386)
3.696
(0.1915–71.33)
0.5812
Hyperlipidemia 31 5 0.9826
(0.7528–1.283)
0.8871
(0.1498–5.253)
1.0000
Diabetes
mellitus
16 3 1.029
(0.8095–1.308)
1.219
(0.2408–6.169)
1.0000
Smoking 9 1 0.9402
(0.7350–1.203)
0.6111
(0.06492–5.753)
1.0000
No. of graft repairs
0 28 5 0.6899
1 10 2
2 4 0
Target vessel stenosis <70% 22 4 1.014
(0.8020–1.283)
1.103
(0.2184–5.569)
1.0000
Target vessel stenosis >70% 32 7 1.116
(0.8925–1.395)
2.273
(0.3955–13.06)
0.4363
Target vessel occlusion 11 1 0.9140
(0.7321–1.141)
0.4697
(0.05068–4.353)
0.6651
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techniques are being developed and used to reduce the
morbidity associated with open technique [10]. Criticisms of
endoscopic vein harvest include increased harvest time,
additional hospital expense, and potential for operative vein
trauma associated with more frequent need for suture repair
of torn side branches (which can compromise the integrity
of the saphenous vein and may inﬂuence long-term graft
patency). Some functional studies assessing the vasoreac-
tivity of vein harvested endoscopically have shown no
differences in endothelium-dependent relaxation (impor-
tant for preserving endothelial integrity of the graft)
between the open and endoscopic techniques [15]. The
increasing experience with endoscopic vein graft harvesting
and modiﬁcations in graft harvesting technique (such as no-
touch technique of harvesting saphenous vein graft with
surrounding tissue and which preserves the adventitial
layer and consequently decreases vascular spasm) have
improved vein quality and patency rates [16]. In our cardiac
surgery department, the bridging technique has been
routinely used as the method of choice for venous graft
harvesting during the last 8 years. Since 2009, we have also
been using the endoscopic method of harvesting. During the
learning period encompassing the ﬁrst endoscopic cases,
and when more than one venous graft was needed,
combined harvests were made using endoscopic and
bridging techniques to reduce the length of the procedure.
As reported in our previous work [17], the introduction of
endoscopic techniques for harvesting vein grafts has been
followed by a decrease in wound complications as compared
to the conventional (bridging) technique, and patient
satisfaction has also been higher with this technique.
There is a still concern about the long-term patency of vein
grafts harvested by endoscopic methods. Yun et al. have
established that the overall occlusion rates at 6 months are
21.7% for endoscopic vein harvest and 17.6% for open veinharvest. Their work presented evidence of signiﬁcant disease
(>50% stenosis) in 10.2% of endoscopic vein harvests and 12.4%
of open vein harvest grafts [18]. Perrault et al. reported the
inﬂuence of patency of saphenous vein grafts to vary
according to the time period of observation. A 10–15% rate
of closure is seen in the ﬁrst month after operation, followed by
another 5–10% attrition rate in the next 11 months [10]. They
indicated no statistically signiﬁcant difference in the patency
rates of vein grafts harvested by endoscopic or open method
(84.4% vs. 85.2%) over a mean follow-up period of 3 months.
Their work also showed no difference in vein graft stenosis
≥50% between the two groups (P = 0.280).
It is important also to comment here on studies reporting
outcomes to the contrary. For example, Zenati et al. have
demonstrated the patency rate for an endoscopic group to be
lower than that of an open harvest group (74.5% vs. 85.2%,
P < 0.0001), and the repeat revascularization rate in their work
was signiﬁcantly higher (6.7% vs. 3.4%, P < 0.05) in a one-year
period [19]. These ﬁndings must be addressed. The results of
this work were from the ROOBY Trial [20]. While that trial
yielded important information about on/off pump bypass
grafting, the information concerning results of one-year
patency of vein grafts after endoscopic and open methods
of harvest is nevertheless misleading. The quality of vein
grafts after endoscopic harvest depends on several factors,
including the open versus closed systems' use of CO2 during
harvest. Some data presented indicated poorer results when
using a closed CO2 system. These include higher occurrence of
adventitial blood clots after harvest due to collapsed vein
lumen during harvest, CO2 emboli into the circulatory system
during the harvest, and problematic aspects relating to
storing of the graft in different types of solutions, surgeon
experience, etc. Their article presents no information about
these variables. In the ROOBY Trial, determining the
advantages or disadvantages of the endoscopic versus open
method of vein harvest was neither a primary nor a secondary
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Lopes et al. demonstrated a higher rate of vein graft failure
(46.7% vs. 38%) and higher rates of death, myocardial
infarction or repeat revascularization (20.2% vs. 17.4%) in
the groups of endoscopically versus open harvested vein
grafts [21]. These results came from the PREVENT IV trial [22],
which also was not focused on endoscopic versus open
methods, and so evaluating these methods was neither a
primary nor a secondary objective of the study protocol. No
information was found concerning the experience of the
surgeon, instrumentation used or storing of the graft. The
experience of the surgeon performing the harvest is in our
opinion the main issue in relation to endoscopic harvest, and
completing at least 50 cases is necessary during the learning
period. With 400 cases having been performed by two
surgeons in our institution, we may state that after the ﬁrst
50 cases, the sensitivity of the surgeon is improving while the
harvesting time and number of defects are simultaneously
decreasing. We believe this study can serve as the basis for
additional research that could support our conclusions and
provide a stronger tool for wider use of endoscopic harvest of
saphenous vein grafts. There are some limitations to this
speciﬁc study in that the total number of patients in the study
is limited.
Conclusions
The goal of this study was to reveal the midterm (two-year)
patency of endoscopically harvested vein grafts as assessed by
means of contrast-enhanced computed tomography.
Our data indicated no association between preoperative
variables and vein graft occlusion. In view of the advantages
and safety of the less-invasive endoscopic technique, and
based on our encouraging results, we recommend the use of
endoscopic saphenectomy in a wide spectrum of patients
undergoing coronary artery bypass surgery.
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